Page last updated: 2024-12-08

4-oxopentanal

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-oxopentanal: an indoor pollutant; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4-oxopentanal : A ketoaldehyde that is pentanal substituted by an oxo group at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID164702
CHEBI ID87363
SCHEMBL ID301539
MeSH IDM0577286

Synonyms (22)

Synonym
4-oxopentanal
626-96-0
4-oxo-pentanal
unii-bl58bk264g
pentanal, 4-oxo-
bl58bk264g ,
SCHEMBL301539
AKOS022632592
2,5-pentanedione
pentane-2,5-dione
KEHNRUNQZGRQHU-UHFFFAOYSA-N
CHEBI:87363
1,4-pentanedione
DTXSID60211655
P17049
lavulinaldehyd
mfcd12545900
Q26841304
levulinaldehyde
A936656
AS-77767
SY282411
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
ketoaldehydeAny compound that has an aldehydic and ketonic group in the same molecule.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (9.09)29.6817
2010's8 (72.73)24.3611
2020's2 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 44.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index44.86 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index5.63 (4.65)
Search Engine Demand Index60.29 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (44.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]